Medicare's therapeutic shoe benefit covers specially designed footwear and custom inserts for qualifying diabetic patients with documented foot complications risk factors, yet utilization remains lower than the benefit's genuine preventive value would suggest — a gap worth understanding given diabetic foot ulceration's serious downstream consequences, including a meaningful association with lower-limb amputation risk when unaddressed.
The Benefit Targets a Specific, Documented High-Risk Population
Medicare's therapeutic shoe benefit is available to diabetic beneficiaries with at least one specific qualifying condition — including peripheral neuropathy with evidence of callus formation, foot deformity, poor circulation, or history of prior foot ulceration or amputation — reflecting an evidence-based targeting approach rather than universal coverage for all diabetic beneficiaries regardless of actual foot complication risk.
Appropriately Designed Footwear Addresses a Genuine, Documented Mechanism
Standard footwear can create pressure points and friction that, for a patient with diabetic peripheral neuropathy and consequently reduced protective sensation, may go unnoticed until a foot ulcer has already developed — therapeutic shoes and custom-molded inserts are specifically designed to redistribute pressure away from vulnerable areas, directly addressing this documented mechanism rather than representing a generic comfort upgrade over standard footwear.
Multiple Barriers Contribute to the Benefit's Underuse
Research examining why this genuinely valuable, Medicare-covered preventive benefit remains underused has identified several contributing factors: limited awareness among both patients and some primary care providers that the benefit exists and what conditions qualify, the administrative requirement for a qualifying physician certification separate from the actual footwear fitting, and a limited number of providers in some areas who are set up to properly fit and bill for the specific therapeutic footwear benefit.
The Required Physician Certification Step Creates a Specific Access Friction Point
The benefit requires a physician to certify that the patient has diabetes and at least one qualifying risk condition, a documentation step that some primary care practices, managing many competing priorities during a standard visit, do not consistently complete even for patients who would clearly qualify — this specific procedural requirement represents an identifiable, addressable friction point distinct from the underlying clinical need or coverage policy itself.
Podiatric Involvement Improves Both Identification and Follow-Through
Diabetes care models that incorporate routine podiatric foot examination, rather than relying solely on primary care to identify qualifying risk factors and initiate the certification and referral process, generally show better therapeutic shoe benefit utilization among eligible patients — this reflects the value of dedicated specialist attention to a specific risk domain that a general primary care visit, covering many competing clinical priorities, may not always adequately address.
The Preventive Value Justifies More Deliberate Attention to This Benefit
Given the documented severity of diabetic foot complications when they progress to ulceration and potential amputation, the relatively modest effort required to identify qualifying patients and complete the certification process represents a favorable prevention investment — diabetes care teams that build systematic screening for therapeutic shoe benefit eligibility into routine care, rather than relying on ad hoc identification, are more likely to actually connect eligible patients with this underused preventive resource.
Conclusion
The Medicare therapeutic shoe benefit addresses a well-documented diabetic foot complication risk mechanism, yet remains underused due to awareness gaps and administrative certification friction rather than any lack of genuine preventive value. Facilities supporting diabetic foot care depend on properly fitted diabetic footwear and foot care supplies to deliver this benefit's preventive value.
